Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SNSE/PFE stock hub

SNSE/PFE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SNSE/PFEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

130.5T

Santiago Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SNSE/PFE

In the news

Latest news · SNSE/PFE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.9

P25 13.4P50 16.4P75 18.1

Trailing P/E18.9

P25 22.5P50 24.4P75 24.4

ROE8.3

P25 9.9P50 12.3P75 18.9

ROIC12.7

P25 12.7P50 13.8P75 19.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SNSE/PFE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CL
Employees	75,000
Employees Change	-7,000%
Employees Change Percent	-7.95
Enterprise value	$176.8T
Exchange	Santiago Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US7170811035
Last refreshed	2026-05-10
Market cap	$130.5T
Price	$27.31
Price currency	USD
Rev Per Employee	779,580,711x
Sector	Healthcare
Sic	2834
Symbol	snse/PFE
Website	https://www.pfizer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.3%
EV Earnings	25.56x
EV/EBIT	10.49x
EV/EBITDA	7.52x
EV/FCF	20.19x
EV/Sales	3.13x
FCF yield	6.71%
Forward P/E	8.86x
P/B ratio	1.56x
P/E ratio	18.86x
P/S ratio	2.23x
PE Ratio10 Y	18.93x
PE Ratio3 Y	24.51x
PE Ratio5 Y	18.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.87%
EBITDA Margin	40.21%
FCF margin	14.98%
Gross margin	74.8%
Gross Profit	$43.7T
Gross Profit Growth	3.59%
Gross Profit Growth Q	-0.71%
Gross Profit Growth3 Y	-9.68%
Gross Profit Growth5 Y	5.93%
Net Income	$6.9T
Net Income Growth	-4.97%
Net Income Growth Q	-9.44%
Net Income Growth3 Y	-36.35%
Net Income Growth5 Y	-6.85%
Pretax Margin	12.49%
Profit Margin	11.83%
Profit Per Employee	$92.2M
ROA	5.69
Roa5y	7.03
ROCE	10.91
ROE	8.31
Roe5y	17.68
ROIC	12.72
Roic5y	18.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.9%
Cagr1y	13.81%
Cagr3y	-12.46%
Cagr5y	-2.97%
Div CAGR10	7%
Div CAGR3	4.04%
Div CAGR5	6.8%
EPS Growth	-5.1
EPS Growth Q	-10.05
EPS Growth3 Y	-36.28
EPS Growth5 Y	-7.08
FCF Growth	-15.48%
FCF Growth Q	23.04%
FCF Growth3 Y	-22.29%
FCF Growth5 Y	-6.79%
OCF Growth	-14.33%
OCF Growth Q	11.99%
OCF Growth10 Y	-2.74%
OCF Growth3 Y	-20.6%
OCF Growth5 Y	-5.39%
Revenue Growth	1.36x
Revenue Growth Q	5.37x
Revenue Growth3 Y	-12.08x
Revenue Growth5 Y	6.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.3
Assets	$191.7T
Cash	$12.1T
Current Assets	$38.2T
Current Liabilities	$30.6T
Debt	$59.8T
Debt EBITDA	$2.45
Debt Equity	$0.72
Debt FCF	$6.83
Equity	$83.5T
Interest Coverage	7.04
Liabilities	$108.2T
Long Term Assets	$153.6T
Long Term Liabilities	$77.6T
Net Cash	$-47.7T
Net Cash By Market Cap	$-36.55
Net Debt EBITDA	$2.03
Net Debt Equity	$0.57
Net Debt FCF	$5.45
Tangible Book Value	$-31.3T
Tangible Book Value Per Share	$-5,488
WACC	6.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.25
Inventory Turnover	1.48
Net Working Capital	$-661.2B
Quick ratio	0.85
Working Capital	$7.8T
Working Capital Turnover	$6,539

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.26%
Dividend Growth	-3.18%
Dividend Growth Years	2%
Dividend per share	$1,577
Dividend Years	15
Dividend Yield	5,773.2%
Ex Div Date	2026-05-08
Last Dividend	$383
Payout Frequency	Quarterly
Payout Ratio	130.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	33.1%
1Y total return	13.8%
200-day SMA	26.28
3Y total return	-32.91%
50-day SMA	26.93
50-day SMA vs 200-day SMA	50over200
5Y total return	-13.98%
All Time High	60.85
All Time High Change	-55.12%
All Time High Date	2021-12-20
All Time Low	22.18
All Time Low Change	23.13%
All Time Low Date	2025-05-14
ATR	0.06
Beta	0.71
Ch YTD	4.8
High52	27.8
High52 Date	2026-04-13
High52ch	-1.76%
Low52	22.18
Low52 Date	2025-05-14
Low52ch	23.13%
Ma50ch	1.42%
Price vs 200-day SMA	3.93%
RSI	59.34
RSI Monthly	39.93
RSI Weekly	74.24
Sharpe ratio	1.18x
Sortino ratio	7.5
Total Return	5,865.29%
Tr YTD	8.26
Tr1m	-0.19%
Tr1w	1.6%
Tr3m	6.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$17.5T
Operating Income Growth	20.65
Operating Income Growth Q	-5.27
Operating Income Growth3 Y	-18.95
Operating Income Growth5 Y	10.43
Operating margin	29.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,691,728,668%
Net Borrowing	1,990,250,570,000
Shares Insiders	0.03%
Shares Institutions	67.59%
Shares Qo Q	0.79%
Shares Yo Y	0.26%
Short Ratio	3.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$7.9T
Average Volume	64x
Bv Per Share	14,599.8
CAPEX	$-2.3T
Ch10y	-19.2
Ch1m	-1.76
Ch1y	4.8
Ch3m	4.8
Ch3y	-44.48
Ch5y	-32.85
Ch6m	4.8
Change	1.6%
Close	26.88
Depreciation Amortization	5,837,949,500,000
Earnings Date	2026-05-05
EBIT	$17.5T
EBITDA	$23.5T
EPS	$1,212
F Score	6
FCF	$8.8T
FCF EV Yield	4.95x
Financing CF	-7,325,768,515,000
Fiscal Year End	December
Founded	1,849
Goodwill	63,646,127,610,000
Graham Number	23.85879
Graham Upside	-12.64
Income Tax	$354.6B
Investing CF	-3,546,067,200,000
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-29
Lynch Fair Value	$7.24
Lynch Upside	-73.49
Ma150	26.35
Ma150ch	3.65%
Ma20	27.36
Ma20ch	-0.18%
Net CF	257,643,945,000
Next Earnings Date	2026-07-28
P FCF Ratio	14.9
P OCF Ratio	11.79
Payment Date	2026-06-12
Ppne	17,292,808,580,000
Price Date	2026-05-08
Price EBITDA	$5.55
Relative Volume	1.1x
Revenue	58,468,553,325,000x
SBC By Revenue	1.42x
Share Based Comp	832,032,955,000
Tax By Revenue	0.61x
Tax Rate	4.86%
Tr6m	8.26%
Z Score	2.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SNSE/PFE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5773.2%

$1577 annual per share

Payout ratio

+130.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.8%

2 consecutive years of growth

Total shareholder yield

+5772.9%

Next ex-dividend date: 2026-05-08

Performance

SNSE/PFE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SNSE/PFE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+67.6%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SNSE/PFE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.3

Neutral momentum band

Price vs 200-day MA

+3.9%

50/200-day relationship not available

Beta (5Y)

0.71

Less volatile than the market

Sharpe ratio

1.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SNSE/PFE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current snse/PFE stock rating?

snse/PFE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full snse/PFE analysis?

The full report lives at /stocks/snse/PFE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for snse/PFE?

The latest report frames snse/PFE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the snse/PFE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.